ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Adlai Nortye Group Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026
$10.38−0.65 (-5.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$8.74 (+532.9%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Adlai Nortye Group Ltd. reported revenue of $5.00M for fiscal 2025. Free cash flow was -$33.64M.
Revenue
$5.00M
FY2025
Operating income
-$35.70M
FY2025
Free cash flow
-$33.64M
FY2025
EPS, diluted
-$0.37
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $5.00M
- Net income
- -$35.53M
- EPS, diluted
- -$0.37
- Free cash flow
- -$33.64M
Six years at a glance
Fiscal years 2020 to 2025, USD
Revenue
$5.00M
Operating income
-$35.70M
Net income
-$35.53M
EPS, diluted
-$0.37
Free cash flow
-$33.64M
Reported period